Skip to main navigation

Skip to content

Search

Toggle search form
- Search for:
Follow us on Twitter
Connect with us on LinkedIn

Investor Relations

Our Team
Our Development Program
Investors/Media
Join Us
Contact Us

Search for:

Press Releases

Infinity Pharmaceuticals, Inc. ASCO Genitourinary Cancers Symposium Call

Feb 11, 2021 at 7:30 AM EST

Listen to webcast

Keyword Search

Year:

Summary Toggle Infinity Announces Closing of $92 Million Public Offering of Common Stock

February 18, 2021 at 8:30 AM EST
Summary Toggle Infinity Announces Pricing of $80 Million Public Offering of Common Stock

February 12, 2021 at 8:30 AM EST
Summary Toggle Infinity Announces Proposed Public Offering of Common Stock

February 11, 2021 at 4:01 PM EST
Summary Toggle Infinity Pharmaceuticals to Present at Upcoming BIO CEO & Investor Conference

February 11, 2021 at 9:25 AM EST
Summary Toggle Infinity Pharmaceuticals Presents Data from Randomized, Placebo-Controlled, Phase 2 MARIO-275 Trial of Eganelisib and Nivolumab in Advanced Urothelial Cancer at ASCO Genitourinary Cancers Symposium

February 11, 2021 at 7:15 AM EST
Summary Toggle Infinity Pharmaceuticals Announces Conference Call for the ASCO Genitourinary Cancers Symposium to Discuss Clinical Data from MARIO-275 Phase 2 Study

February 10, 2021 at 4:05 PM EST
Summary Toggle Infinity Pharmaceuticals to Participate in B. Riley Securities Virtual Oncology Investor Conference

January 15, 2021 at 8:35 AM EST
Summary Toggle Infinity Pharmaceuticals Announces MARIO-275 Phase 2 Data in Patients with Advanced Urothelial Cancer to be Presented at ASCO Genitourinary Cancers Symposium

January 11, 2021 at 8:05 AM EST
Summary Toggle Infinity Pharmaceuticals to Participate in Three Investor Conferences This Month

January 7, 2021 at 8:35 AM EST
Summary Toggle Infinity Pharmaceuticals Provides Update for Eganelisib in Patients with Metastatic Urothelial Cancer

January 6, 2021 at 9:11 AM EST

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Shareholder Tools

RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Print

Print
Email

Email

Infinity Pharmaceuticals, Inc.

1100 Massachusetts Ave
Cambridge, MA 02138
617-453-1000

Terms and Conditions

Terms & Conditions
Privacy Policy
Forward Looking Statements

Connect With Us

Our Team

Our Team

Our Development Program

Our Development Program

Investor / Media

Investors/Media

Join Us

Join Us

© 2021 Infinity Pharmaceuticals, Inc. All Rights Reserved.